$XLNX Xilinx Inc (XLNX) Overall Average: 96% Buy. Wednesday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$XLNX Overall Average: 96% Buy. $MXIM $CMCSA $NVDA

Xilinx Inc (XLNX) Buy - Hold - Sell - Overall Opinion

XLNX Last Price: 51.50
Current Change: +0.16 (+0.31%)

Composite Indicators - Signal
TrendSpotter- Buy

Short Term Indicators
7 Day Average Directional Indicator- Buy
10 - 8 Day Moving Average Hilo Channel- Buy
20 Day Moving Average vs Price- Buy
20 - 50 Day MACD Oscillator- Buy
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 80% Buy
20-Day Average Volume - 4,235,940



Medium Term Indicators
40 Day Commodity Channel Index- Buy
50 Day Moving Average vs Price- Buy
20 - 100 Day MACD Oscillator- Buy
50 Day Parabolic Time/Price- Buy

Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 3,443,656

Long Term Indicators
60 Day Commodity Channel Index- Buy
100 Day Moving Average vs Price- Buy
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 100% Buy
100-Day Average Volume - 3,224,189

Overall Average: 96% Buy

Price - Support - Pivot Point - Resistance
51.50 50.78 51.41 52.04


Last Updated: Wednesday, February 26, 2014 08:47:31 AM

XLNX Stock Message Board and Forum http://investorshangout.com/search?q=XLNX&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Important Legal Opportunity for Coinbase Investors in Class Action

Updated Category News Views 114

Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...

Continue Reading
BridGene Biosciences Secures $28 Million for Drug Development

Updated Category News Views 244

BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...

Continue Reading
NMD Pharma Breaks Ground with NMD670 in Rare Neuromuscular Treatment

Updated Category News Views 177

NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...

Continue Reading
Becker Milk Company Limited Announces Half-Year Financial Overview

Updated Category News Views 89

Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...

Continue Reading
Mini Melts Collaborates with 7-Eleven for Blue Raspberry Flavor

Updated Category News Views 354

Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...

Continue Reading